Drug: NEORAL Injury: Hepatic function abnormal Quarter: 2016Q3
Total Records: 10 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
123796443 | NEORAL | Hepatic function abnormal | ROCHE | 71.88 YR | M | 0 | 20160804 | JP |
124638956 | NEORAL | Hepatic function abnormal | SANDOZ | 62.69 YR | M | 0 | 20160925 | JP |
126296331 | NEORAL | Hepatic function abnormal | GLAXOSMITHKLINE | 90.00 YR | F | 0 | 20160808 | IE |
126891321 | NEORAL | Hepatic function abnormal | AMGEN | 34.00 YR | M | 0 | 20160826 | CA |
126949221 | NEORAL | Hepatic function abnormal | PFIZER | 34.00 YR | M | 0 | 20160829 | CA |
126950026 | NEORAL | Hepatic function abnormal | SANDOZ | 66.00 YR | F | 42 KG | 20160921 | JP |
127100111 | NEORAL | Hepatic function abnormal | ORION | 34.00 YR | M | 0 | 20160902 | CA |
127170661 | NEORAL | Hepatic function abnormal | MYLAN | 0.00 | 0 | 20160906 | IE | |
127338771 | NEORAL | Hepatic function abnormal | ROCHE | 34.00 YR | M | 0 | 20160912 | CA |
127606301 | NEORAL | Hepatic function abnormal | TEVA | 90.00 YR | F | 0 | 20160919 | IE |
Total Records: 10 Number of Pages: 1